TIAA CREF Investment Management’s Alder Biopharmaceuticals ALDR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	$10.2M	Sell	750,772 -644,837	-46%	-$8.35M	0.01%	1029
2018 Q4	$14.3M	Buy	1,395,609 +346,476	+33%	+$4.44M	0.01%	791
2018 Q3	$17.5M	Buy	1,049,133 +925,463	+748%	+$16.7M	0.01%	795
2018 Q2	$1.95M	Sell	123,670 -51,620	-29%	-$784K	﹤0.01%	2188
2018 Q1	$2.23M	Sell	175,290 -219,299	-56%	-$3.17M	﹤0.01%	2045
2017 Q4	$4.52M	Buy	394,589 +229,010	+138%	+$2.56M	﹤0.01%	1665
2017 Q3	$2.03M	Buy	165,579 +235	+0.1%	+$2.45K	﹤0.01%	2158
2017 Q2	$1.89M	Buy	165,344 +22,277	+16%	+$412K	﹤0.01%	2215
2017 Q1	$2.98M	Sell	143,067 -6,889	-5%	-$153K	﹤0.01%	1905
2016 Q4	$3.12M	Buy	149,956 +8,744	+6%	+$227K	﹤0.01%	1928
2016 Q3	$4.63K	Sell	141,212 -2,728	-2%	-$83.1K	﹤0.01%	1660
2016 Q2	$3.59M	Buy	143,940 +74,036	+106%	+$2M	﹤0.01%	1768
2016 Q1	$1.71M	Sell	69,904 -3,897	-5%	-$90.2K	﹤0.01%	2169
2015 Q4	$2.44M	Hold	73,801	–	–	﹤0.01%	2027
2015 Q3	$2.42M	Buy	73,801 +3,778	+5%	+$161K	﹤0.01%	2032
2015 Q2	$3.71M	Buy	70,023 +36,450	+109%	+$1.33M	﹤0.01%	1899
2015 Q1	$969K	Buy	33,573 +5,033	+18%	+$138K	﹤0.01%	2637
2014 Q4	$830K	Sell	28,540 -5,044	-15%	-$90.5K	﹤0.01%	2756
2014 Q3	$426K	Buy	33,584 +2,780	+9%	+$42K	﹤0.01%	3010
2014 Q2	$618K	Buy	+30,804	New	+$434K	﹤0.01%	2956